Edmundo Pichardo
- New
- 38 years of experience
- Mexico, Mexico City, DR. IRERI ASTEINZA Clinic
Functional/Holistic Medicine
Medical Nutrition, Elimination diet
Autoimmune diseases
Lifestyle Medicine, Epigenetics
Intestinal permeability, Liver Diseases, Candida
Insulin resistance, Obesity treatment
Longevity
Temperature Medicine
Aromatherapy, Schusler Salts
Preventive Medicine
Skin diseases, Histamine sensitivity
Brain fog, memory impairment, Hyperactivity
Depression, anxiety, anxiety disorder. ……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………..
EDUCATION:
2015
Uludag University, Ophthalmology
2008
Eskisehir Osmangazi University, Faculty of Medicine
2001
Kırıkkale Science High School, Numerical
EXPERIENCE:
2019 Gazi University Faculty of Medicine Ophthalmology (Vitreo-Retinal Surgery and Medical Retina Fellowship)
2016 SBÜ Zekai Tahir Burak EAH (Retinopathy of Prematurity Fellowship)/
2015 - 2023 Kocaeli Derince Training and Research Hospital
2023 - Medipol University Pendik Hospital
Dr. Luis Padilla is a physician who specializes in gynecologic oncology, general practice, and healthcare administration. He helped introduce the da Vinci Robotic Assisted Surgical System, which improved minimally invasive surgery.
Dr. Padilla has worked as Associate Administrator for Health Workforce at HRSA. He also served as Director of the NHSC. In these roles, he influenced national health policy and workforce training. He has received the People’s Choice Award and the People Living Through Cancer Award for his commitment to patient care.
He served on the National Advisory Council of the NHSC from 2007 to 2010. He earned degrees from UC Irvine, Wake Forest, Brown, Northwestern, and the University of Minnesota.
Dr. Séverine Iborra is the Chief Physician of the Department of Gynecology and Obstetrics at Städtisches Klinikum Solingen. Her responsibilities include obstetrics, the delivery room, the neonatal unit, and gynecology. The department also includes the Senology/Breast Clinic at the Bergisches Breast Center Solingen, led by Dr. Manuela Seifert.
Dr. Séverine Iborra is originally from France. She began her medical studies at the University of Lyon and later transferred to Albert-Ludwigs University in Freiburg, where she received her medical license in 2007. She earned her doctorate in 2008 for experimental research in molecular oncology. From August 2008 to November 2013, Dr. Iborra worked as a resident at the University Women’s Clinic in Freiburg. After passing her specialist exams in gynecology and obstetrics, she continued her career as a specialist at the same clinic. In November 2015, she moved to RWTH University Hospital Aachen as a senior physician.
At the Clinic for Gynecology and Obstetrics, under the leadership of Prof. Dr. E. Stickeler, Dr. Iborra led the obstetrics department from 2017 to 2019. Since December 2017, she was responsible for organizing education in the department, and in October 2019, she became the Managing Senior Physician and Personnel Senior Physician of the clinic, a position she held until she moved to Solingen.
In addition to her scientific work, with numerous publications and presentations at major gynecological conferences, Dr. Iborra deepened her medical specialties. She obtained certifications in oncological diagnostics and therapy from the Gynecological Oncology Working Group, as well as additional qualifications in Cervical Pathology and Colposcopy (AGCPC), Urogynecology and Pelvic Reconstructive Surgery (AGUP), and the Professional Association of Gynecologists (BVF).
In 2019, Dr. Iborra successfully completed further specialization in “Gynecological Oncology” and “Special Obstetrics and Perinatal Medicine.” She is an active member of leading German medical societies in her field, including the German Society for Gynecology and Obstetrics, the Cervical Pathology and Colposcopy Working Group, and the German Society for Prenatal and Birth Medicine.
Treatments Offered in Our Gynecology Department
Whenever possible, we offer all procedures as minimally invasive treatments using laparoscopy or the Da Vinci robotic system.
Professor Markus Dukes is a specialist in diagnostic radiology and minimally invasive therapy.
Marcus Dukes is one of the first physicians to perform minimally invasive microwave ablation of liver and lung tumors under CT guidance.
The professor heads the first and only MRI-guided FUS ablation center in the Rhine-Main region. In most cases, the procedure allows avoiding surgical intervention. Patients of the center have access to ablation for prostate cancer, bone and liver metastases, benign tumors, and treatment of uterine fibroids without surgery.
20 top ranked Diagnostics doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 Diagnostics doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous Diagnostics doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on Diagnostics varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for Diagnostics if you have any difficulties with a choice. Bookimed services are free for patients ♥
EDUCATION:
2000 - SSK Okmeydanı Training and Research Hospital, .
1996 - Istanbul University, Istanbul Faculty of Medicine
EXPERIENCE:
2019 - Istanbul Medipol University Pendik Hospital
2017 - 2019 - Private Adatıp Kurtköy Hospital
2005 - 2017 - Private Avicenna Umut Hospital
2003 - 2005 - SSK Yalova Regional Hospital
2002 - 2003 - Kayseri Military Hospital
Membership in societies:
Expert of scientific journals
Close co-operation with leading surgeons
Membership of the German Medical Association
Specialities:
Introduction of new and modern techniques in the field of oncological surgery
General and visceral surgery
Minimally invasive surgery
Gastrointestinal oncology surgery
Oncological surgery
Haemorrhoids treatment
Additional clinical specialisation in minimally invasive and hernia surgery
Surgery and transplantation of the pancreas
Work Experience:
2005: Specialist in the field of surgery
2008: Appointed Senior Consultant specialising in pancreatic surgery and transplantation
2010: Coordinator of the Pancreatic Cancer Centre (Oncocert)
2013: Specialist in visceral surgery
2014: Managing Senior Physician, additional clinical specialisation in minimally invasive and hernia surgery
2019: Chief Surgeon of the Colorectal Cancer Centre Bochum (the first certified colorectal cancer centre in Germany and one of the first certified leading colorectal centres in Europe)
2021: Chief Surgeon of the Department of Surgery at the Academic Hospital Solingen
Thanks to the professor and his team, the department has been modernised by introducing modern surgical methods of treatment and especially improved methods of post-operative recovery. The Department of Surgery at the Solingen Clinic is now further expanding its focus on minimally invasive surgery in the direction of robotics. The clinic has allocated a huge budget for the purchase of state-of-the-art equipment in order to offer patients a full range of surgical methods for the treatment of benign and malignant diseases of the oesophagus, lungs, stomach, liver, pancreas and intestines according to current guidelines and using the most modern technical equipment.
Professor Schenker is an active researcher and lecturer. He lectures at medical universities and organises seminars and workshops for colleagues. He cooperates closely with the Cancer Centre, the Pancreatic Cancer Treatment Centre, the Intestinal Cancer Treatment Centre and the Interregional Trauma Centre.
Dr. Levent Dalar is a respected pulmonologist with over 20 years of experience. He specializes in interventional bronchoscopy and rare lung diseases. Dr. Dalar has trained and worked in France, Switzerland, and Turkey. He gained valuable experience at the University of Zürich’s Lung Transplant Unit. His background gives him a broad view of advanced lung care.
Dr. Dalar is known for his work in bronchoscopic techniques. He has diagnosed and treated thousands of complex respiratory cases. His main focus is on interstitial lung diseases and respiratory deficiencies. As a professor, he helps train future specialists at top universities. He is also an active member of ERS, EABIP, SPLF, and GELF, staying involved in the latest developments in respiratory medicine.
Citizenship : Turkmenistan
Place / Date of Birth: Turkmenistan / 1988
EDUCATION STATUS
2005-2011 Medical Education: Istanbul Faculty of Medicine
2013 – 2018 Specialization Training: M.S Baltalimani Bone Diseases Training and Research Hospital
WORK EXPERIENCE
2018 – 2021 year: Private Baypark Hospital
2021 -2022 year : Private TRG Hospitalist Hospital
2022- : Private Küçükçekmece Hospital
EDUCATION AND SEMINARS
Various Orthopedics congresses with national and international participation
FOREIGN LANGUAGE
English Russian
ORGANIZATIONS OF ITS MEMBERSHIP
Turkish Medical Association
Turkish Orthopedic Association Association
AREAS OF EXPERTISE
Trauma surgery (Fractures-dislocations)
Sports and soft tissue injuries (Anterior cruciate ligament, meniscus, other ligament and tendon tears)
Knee-Shoulder-Ankle Arthroscopy
Calcification of the Joints Diagnosis and Treatment (Knee, Hip, Shoulder, Ankle)
Prosthetic Surgery
Pediatric Orthopedics (Congenital hip dislocation, clubfoot..)
Diagnosis and Treatment of Spinal Diseases
Hand and Microsurgery
MSc Faculty of Medicine (ING) Hacettepe University 1991-1997
Specialization Department of Pediatrics Dicle Universityniversitesi 1997-2002
Minor Cerrahpaşa Faculty of Medicine Pediatric Hematology & Oncology Department Istanbul University 2006-2009
Bone Marrow Transplant Unit MP Göztepe Hospital 2012-2013
Assistant Professor
Afyon Kocatepe University/Faculty of Medicine/Internal Medical Sciences
2003-2009 Department/ÇDepartment of Pediatrics)
Assistant Professor
Istanbul University/Cerrahpaşa Faculty of Medicineltesi/Internal Medical Sciences
2006-2009 Department of Pediatrics)
Pediatric Hematology Specialist Diyarbakır Children's Hospital, Pediatric Hematology compulsory service 2009-2012
Transfer Ünitesi Assistant Hematology Specialist Private Medical Park Göztepe Hospital Bone Marrow Transplant Unit Assistant Responsible Pediatric Hematology Specialist
2012-2013
Assistant Professor
Akdeniz University / Faculty of Medicine / Department of Internal Medical Scienceslümü/Department of Pediatrics)
2013-2014
Assistant Professor Marmara University/Faculty of Medicine/Department of Internal Medical Sciences/Department of Pediatrics) 2014-2024
Turkish Society of Hematology
Turkish Pediatric Hematology Association
Marmara Pediatric Association
Turkish Pediatric Society
Istanbul Medical Chamber
EBMT (European Bone Marrow Transplantation)
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Education
Studied at the Medical School of the University of Giessen, Germany (1996 - 2003)
Specialization in Pathology (2009)
Specialization in Gastroenterology (2012)
Professional Experience
Resident in Special Pathology at Klinikum Offenbach, Germany (Jul 2003 - Aug 2009)
Resident in Gastroenterology at Klinikum Offenbach, Germany (Aug 2009 - Dec 2012)
Commissioner of the Gastroenterology Clinic at Klinikum Offenbach, Germany Apr 2010 - Aug 2014 (Director: Prof. Dancygier Apr 2010-Mar 2014, Prof. Ell Apr 2014 - Aug 2014)
Senior Attending Physician (Deputy Director) at the Department of Gastroenterology, Kreiskliniken Darmstadt-Dieburg Hospital, Germany Sep 2014 - Dec 2020 (Director Dr. Dotzel)
Director of the Gastroenterology Department at the German Oncology Centre in Limassol, Cyprus (Jan 2021 to date)
Education
2002 Haydarpaşa Numune Training and Research Hospital, Internal Medicine
1990 Erciyes University, Faculty of Medicine
Experience
2019 - 2019 Okan University Hospital
2018 - 2019 Ibn Sina Hospital
2003 - 2018 Pendik State Hospital
1997 - 2003 Haydarpasa Numune Hospital
1990 - 1994 Erzincan State Hospital
Istanbul Haydarpasa Numune Hospital
Kartal Health Group Presidency
Yıldırım Beyazıt Mother and Child Health Physician